GlassScriptPhysician profile
Beth R Davis
NPI 1740455997
$1,320.14
in general payments reported to CMS, 2019-2025
22 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $12.63 · 2022: $178 · 2023: $548 · 2024: $243 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $264.84 | 2023 | Myrisk |
| Astellas Pharma US INC | $135.77 | 2022-2024 | Veozah |
| Abbvie INC. | $132.31 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $105.95 | 2023-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Millicent US INC | $82.55 | 2024 | Intrarosa, Femring |
| Myovant Sciences INC. | $60.49 | 2022 | |
| Pfizer INC. | $59.86 | 2022-2023 | |
| Coopersurgical, INC. | $55.27 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $54.26 | 2023-2024 | |
| Exeltis, USA INC. | $48.53 | 2023-2024 | Slynd |
| Covidien LP | $45.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.65 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $36.45 | 2025 | Myfembree |
| Organon LLC | $34.47 | 2022-2024 | |
| Sage Therapeutics, LLC | $34.20 | 2024-2025 | Zurzuvae |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.46 | 2022 | |
| Merck Sharp & Dohme LLC | $23.67 | 2019-2021 | |
| Monaghan Medical Corporation | $20.02 | 2024 | Aeroeclipse |
| Exact Sciences Corporation | $17.40 | 2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $15.38 | 2023 | Phexxi |
| Northgate Technologies, INC. | $14.98 | 2024 | Stimsite |
| Scynexis, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.